HOXA5 and colorectal adenocarcinoma: To further confirm that the promoters of HOXA5, HOXA2, and HOXA6 have aberrant methylation patterns in CRC, nine paired colorectal adenocarcinoma samples and adjacent non-tumor colorectal tissue samples and four CRC cell lines were selected for MethylTargetTM assays.